|
Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer Clinical research trials and Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer. Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer clinical trial. Human subjects often obtain the finest healthcare possible for their Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer  Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer
Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer
For Condition: Non Small Cell Lung Cancer,Stage 3A non small cell lung cancer,Lung Cancer,Stage 3B non small cell lung cancer
Status: Recruiting
Sponsor(s): Shionogi ,
Synopsis: A study to measure the safety and effectiveness of S-3304 when given in combination with conventional chemo-radiation therapy in patients with locally advanced non-small cell lung cancer.
Details: A two part study to evaluate the safety and efficacy of S-3304 in combination with standard therapy in patients with locally advanced non-small cell lung cancer. The first part of the study is a Phase I design to evaluate the maximum tolerated dose of S-3304 when given in combination with radiation and paclitaxel/carboplatin chemotherapy that is appropriate for further evaluation. The second part of the study is a randomized Phase II design to evaluate the efficacy of recommended S-3304 dose in combination with chemo-radiation.
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/85 Years
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA - newly diagnosed non-small cell lung cancer of stage IIIA non-resectable or of stage IIIB without pleural effusion - ECOG performance status 0-1 - adequate organ function - clinically indicated and able to receive conventional chemoradiation therapy EXCLUSION CRITERIA - patients with prior history of cancer, other than basal cell carcinoma after appropriate treatment, or prior systemic chemotherapy treatment - patients with other serious intercurrent illness including HIV/AIDS, or contraindicated for paclitaxel/carboplatin or thoracic irradiation treatment
Total Enrollment: 90
Location and Contact Information:
University of Kansas Cancer Center *Recruiting*
Kansas City, Kansas, 66160
United States
Recruiting Rebecca Clark-Snow 913-588-4714
The Cleveland Clinic *Recruiting*
Cleveland, Ohio, 44195
United States
Recruiting Deb Camino 216-445-3484
Scripps Cancer Institute *Recruiting*
La Jolla, California, 92037
United States
Recruiting S-3304 Coordinator 858-882-8322
VA Medical Center-East Orange (study available to veterans only) *Recruiting*
East Orange, New Jersey, 07108
United States
Recruiting Ilda Boholli 973-395-7087
Lombardi Cancer Center *Recruiting*
Washington D.C., District of Columbia, 20007
United States
Recruiting Sharon Levy 202-687-8921
Additional Information:
Study ID Numbers: 0207P1421;
Study Start Date: February 2003
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00078390
Other Lung Cancer Studies:
1. Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
2. Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
3. Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
4. Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer
5. Study of PT-100 and Docetaxel in Advanced Non-Small Cell Lung Cancer
Related Studies:
Other Lung Cancer Clinical Trials
Other Ohio Clinical Trials
Other Cleveland Clinical Trials
Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer
|
|
|
|
|
|
|
|
